Cyclarity Therapeutics

WATCH The Future of Longevity AT: https://lnkd.in/gdsQiRa4 Many thanks and #Gratitude to Omri Amirav-Drory and Eric Ward at NFX for creating this documentary featuring scientists making a difference in the field of #longevity. We are honored they chose to include Cyclarity Therapeutics ' CEO, Scientific Affairs, Matthew "Oki" O'Connor, Head of, Head of Scientific Computing, Amelia Anderson and Vice President of Biology, Daniel Clemens. Love the animations!! Based at the Buck Institute for Research on Aging in Novato, #California, US, we are working to reverse atherosclerosis. Our mission to provide a drug (UDP-003) that can genuinely modify the course of primary coronary heart disease, peripheral artery disease, and carotid stenosis. The drug is clinic-ready (in vials and labeled, and the safety package is being finalized). We expect phase 1 to be performed in Australia under the direction of the Victoria Heart Institute in 2024, with a multi-country, multi-site phase 2 in ’25 through ‘27. The company is currently raising a Series A-1 to fund the phase 1 trial. #JPM #JPM24 #JPM2024 #Healthspan #LifescienceVC #VentureCapital #investments #lifesciences #cyclarity #ReverseAtherosclerosis #CuringHeartDisease #endheartdisease #atherosclerosis #CuringAtherosclerosis #DiseaseReversal #HeartHealth #CardiovascularDisease #cyclodextrin #cholesterol #ScienceNeverSleeps #LiveBetterLonger #ResearchNeverSleeps #ForeverHealthy #Kizoo #Australia #US #EU #SanFrancisco #longevitylifestyle #longevitymedicine

Exciting News! 🎉 We at Cyclarity are thrilled to announce that we have officially submitted our trial application to the Human Research Ethics Committees (HREC) in Australia for our First in Human clinical trial! This milestone marks our transition to a clinical-stage company, and we couldn’t be more proud of our hardworking team in California. 🙌 Our upcoming clinical trial will be conducted at CMAX in Adelaide, partnered with Monash University under the esteemed guidance of Dr. Stephen Nicholls, a world-renowned cardiologist and leader at the Victorian Heart Institute (VHI). Stay tuned for more updates as we embark on this exciting journey towards groundbreaking advancements in healthcare! #Cyclarity #ClinicalTrial #HREC #Milestone #HealthcareInnovation #Cardiology

Dr. O'Connor speaking at Longevity Summit Dublin in June. Take a look! https://lnkd.in/dT-nqzcv

Dr. Daniel M. Clemens, our V.P. of Biology, will be presenting at the 2024 European Atherosclerosis Society Congress in Lyon on Tuesday, May 28. Daniel will be presenting new and exciting data about the efficacy and clinical readiness of UDP-003, our intended first-in-class therapeutic for the reversal of atherosclerosis. Come by the Science at a Glance presentation, or contact Daniel directly to setup a meeting. https://lnkd.in/d9_HdhvE To contact Daniel: https://lnkd.in/gyMZKH7V Visit https://cyclaritytx.com to learn more about our revolutionary approach to curing heart disease. #cyclarity #cureheartdisease #EASCongress2024 #EAS2024 #atherosclerosis #CVD #cholesterol

CONGRATULATIONS to our Head of Scientific Computing & Co-Founder, Dr. Amelia Anderson, for achieving a PhD summa cum laude for her novel work in computational molecular modeling, which is central to Cyclarity’s approach to curing heart disease! #cyclarity #cureheartdisease #cyclodextrins

Meet the Cyclarity Tx team @ #RejuvenationStartupSummit2024. Presented by Forever Healthy, the summit brings together world-leading rejuvenation startups, members of the rejuvenation/longevity venture capital ecosystem, and the wider investment community. May 10-11, 2024 in Berlin Learn more at https://lnkd.in/gJYzViw7 Attending from Clyclarity will be: - Michael Kope: CEO, Corporate Affairs - Dr. Matthew O’Connor: CEO, Scientific Affairs - Dr. Daniel Clemens: VP of Biology - Amelia Anderson: Head of Scientific Computing - Dr. Noah Rosenberg: Head of Clinical Affairs For inquiries, contact [email protected] For more info on our revolutionary approach to curing atherosclerosis, visit https://cyclaritytx.com #cyclarity #ReverseAtherosclerosis #CuringHeartDisease #endheartdisease #atherosclerosis #CuringAtherosclerosis #DiseaseReversal #HeartHealth #CardiovascularDisease #Healthspan #Lifespan #Lifescience #VentureCapital #Biotech #California #Berlin #Longevity

Thank you Frank Schueler and Forever Healthy for creating this amazing opportunity to see the cutting edge in Longevity and Rejuvenation biotechnologies - exceptionally curated and impeccably hosted. Not to be missed for investors, startups, and scientists alike. We've been honored and grateful to participate and look forward to this year's event! #RejuvenationStartupSummit2024

Program and full speaker list of the #RejuvenationStartupSummit 2024 (May 10-11) released today! Join the largest gathering of longevity CEOs in person and get your ticket as long as it is Early Bird (Early Bird pricing ends March 1)! Starting midday on Friday and finishing off on Saturday night with a big party, it offers ample opportunity to get in touch, learn, and network with some of the most promising companies in the rejuvenation/longevity field like: * Mehmood Khan, CEO of the Hevolution Foundation * Nina Ruge, science journalist and best-selling author  * Dobri Kiprov, CSO of Lyfspn  * Greg Fahy, CSO, and Robert T. (Bobby) Brooke, CEO and CTO of Intervene Immune * Aaron Friedman, CEO, and Vlad Senatorov, CSO of Reservoir Neuroscience * Marco Quarta, CEO Rubedo Life Sciences * Robin Mansukhani, CEO of Deciduous Therapeutics * Matthias Breugelmans, CEO, and Naren Vyavahare, CSO of Elastrin Therapeutics * Alex Blyth, CEO of LIfT BioSciences  * Ann Belien, PhD Belien, CEO of Rejuvenate Biomed  * Michael Kope, and Matthew "Oki" O'Connor, Co-CEOs of Cyclarity * Lukas Langenegger, CEO of Hemotune * Aaron Cravens, CEO of REVEL  * Christopher Bradley, CEO of MatterBio * Nikolina Lauc, CEO of Glycan Age  * Janine Sengstack, Co-founder and CEO, and Rob Carhill, Co-Founder and President of Junevity * Reason, CEO and Mourad Topors, CSO of Repair Biotechnologies * Alexander Leutner, Managing Director of cellbricks * Dr. Alexander Schueller, CEO, and Stephen Helliwell, CSO of cellvie * Louis Hawthorne, CEO of NaNotics  * Celine Halioua, CEO of Loyal * Phil Newman, CEO of Longevity.Technology * Stephanie Lauren Dainow , Executive Director of Lifespan.io  * Francois Casanova, CEO of AYUN Health & Longevity Center * Joanna Bensz, CEO of Longevity Center Europe * Sophie Chabloz, CPO of Avea  * Lorna Harries, CSO of Senisca * Alejandro Ocampo, Co-founder and CEO of Epiterna * Juergen Reess, CEO of Mogling Bio * Petr Sramek, Co-founder of the Healthy Longevity Clinic and Managing Partner of LongevityTech.fund * Brian Kennedy, Prof. at National University of Singapore * Eric Verdin, CEO and President of the Buck Institute for Research on Aging Investors on stage: * Jens Eckstein, Investment Partner at Hevolution * Alex Colville, Co-founder and General Partner at Age1 * Jan Adams, Partner at Apollo Health Ventures * Sergey Jakimov, Managing Partner at LongeVC * Marc P. Bernegger, Founding Partner at maximon * Patrick Burgermeister, Partner at Kizoo Technology Capital Please find the full conference program featuring over 40 speakers leading the industry here: https://lnkd.in/e6Fv8bVG Early bird pricing for the Rejuvenation Startup Summit 2024 ends March 1! Get your tickets here: https://lnkd.in/emmPysKd #RejuvenationStartupSummit #longevity #aging #ageing #rejuvenation 

Cyclarity is looking forward to participating in this important and visionary conference! Thank you Frank Schueler and Forever Healthy for your work in helping to bring rejuvenation biotechnologies to the world! #RejuvenationStartupSummit #Endheartdisease #cyclarity

Resolving the Cholesterol Controversy By Gilbert R Thompson (Imperial College London, UK) Resolving the Cholesterol Controversy recounts the science and scientific personalities behind the chain of discoveries upon which the lipid hypothesis of atherosclerosis was built. Find out more https://lnkd.in/ePvDqefj